This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Bionano Genomics Yönetim
Yönetim kriter kontrolleri 2/4
Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 12.83 years. total yearly compensation is $2.77M, comprised of 19.7% salary and 80.3% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €66.79K. The average tenure of the management team and the board of directors is 1.8 years and 4.5 years respectively.
Anahtar bilgiler
Robert Holmlin
İcra Kurulu Başkanı
US$2.8m
Toplam tazminat
CEO maaş yüzdesi | 19.7% |
CEO görev süresi | 12.8yrs |
CEO sahipliği | 0.1% |
Yönetim ortalama görev süresi | 1.8yrs |
Yönetim Kurulu ortalama görev süresi | 4.5yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2023 | n/a | n/a | -US$147m |
Mar 31 2023 | n/a | n/a | -US$140m |
Dec 31 2022 | US$3m | US$544k | -US$133m |
Sep 30 2022 | n/a | n/a | -US$117m |
Jun 30 2022 | n/a | n/a | -US$106m |
Mar 31 2022 | n/a | n/a | -US$92m |
Dec 31 2021 | US$8m | US$484k | -US$72m |
Sep 30 2021 | n/a | n/a | -US$61m |
Jun 30 2021 | n/a | n/a | -US$51m |
Mar 31 2021 | n/a | n/a | -US$41m |
Dec 31 2020 | US$708k | US$376k | -US$41m |
Sep 30 2020 | n/a | n/a | -US$37m |
Jun 30 2020 | n/a | n/a | -US$33m |
Mar 31 2020 | n/a | n/a | -US$32m |
Dec 31 2019 | US$899k | US$404k | -US$30m |
Sep 30 2019 | n/a | n/a | -US$28m |
Jun 30 2019 | n/a | n/a | -US$27m |
Mar 31 2019 | n/a | n/a | -US$23m |
Dec 31 2018 | US$3m | US$390k | -US$18m |
Sep 30 2018 | n/a | n/a | -US$18m |
Jun 30 2018 | n/a | n/a | -US$18m |
Mar 31 2018 | n/a | n/a | -US$22m |
Dec 31 2017 | US$605k | US$379k | -US$23m |
Tazminat ve Piyasa: Robert's total compensation ($USD2.77M) is above average for companies of similar size in the German market ($USD418.12K).
Tazminat ve Kazançlar: Robert's compensation has been consistent with company performance over the past year.
CEO
Robert Holmlin (55 yo)
12.8yrs
Görev süresi
US$2,766,572
Tazminat
Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and serves as its Secretary. D...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.8yrs | US$2.77m | 0.14% € 66.8k | |
Chief Operating Officer | 6yrs | US$1.50m | 0.47% € 232.2k | |
Chief Medical Officer | 3.3yrs | US$1.32m | 0.0013% € 625.6 | |
Chief Financial Officer | less than a year | Veri yok | Veri yok | |
VP of Accounting & Controller | 5.4yrs | Veri yok | Veri yok | |
General Counsel | 1.8yrs | Veri yok | 0.010% € 5.1k | |
Vice President of Global Sales | 1.8yrs | Veri yok | Veri yok | |
Global Head of Market Access | less than a year | Veri yok | Veri yok | |
Global Head of People Operations | 1.8yrs | Veri yok | Veri yok |
1.8yrs
Ortalama Görev Süresi
49.5yo
Ortalama Yaş
Deneyimli Yönetim: 2Y30's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.8yrs | US$2.77m | 0.14% € 66.8k | |
Independent Director | 5.3yrs | US$224.42k | 0.017% € 8.4k | |
Independent Chairman of the Board | 13.5yrs | US$249.42k | 0.015% € 7.6k | |
Independent Director | 12.1yrs | US$229.42k | 0% € 0 | |
Independent Director | 3.5yrs | US$211.92k | 0.017% € 8.6k | |
Independent Director | 4.5yrs | US$221.92k | 0% € 0 | |
Independent Director | 3.5yrs | US$209.42k | 0% € 0 | |
Independent Director | 1.9yrs | US$214.42k | 0% € 0 | |
Independent Director | 1.8yrs | US$451.18k | 0% € 0 |
4.5yrs
Ortalama Görev Süresi
58yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 2Y30's board of directors are considered experienced (4.5 years average tenure).